Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

In an emailed statement to The Fly, Novavax (NVAX) said, “As we have previously stated, we believe that our Biologics License Application for ...

An independent vaccine advisory committee to the Centers for Disease Control and Prevention met to discuss and vote on ...

With former director of the FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., out of the picture, ...